Skip to Main Content


RGA’s ROSEBUD Program Receives NCQA Accreditation for the Second Time

MINNEAPOLIS, April 3, 2019 – RGA Reinsurance Company, a subsidiary of leading global life and health reinsurer Reinsurance Group of America, Incorporated, today announced that it has received another three-year accreditation from the National Committee for Quality Assurance (NCQA) for RGA’s ROSEBUD® Perinatal and Neonatal Case Management programs. This is the second consecutive NCQA Case Management accreditation ROSEBUD has earned.

“We are so proud to once again receive the three-year accreditation from NCQA acknowledging the high quality of the ROSEBUD case management program,” said Barbara Clay, Vice President Medical Management, RGA. “We work diligently to provide our clients with dedicated support from expert perinatal and neonatal nurse consultants, and we are pleased that our commitment to performance and compliance with the NCQA standards is being recognized.”

NCQA Accreditation standards are purposely set high to encourage organizations to continuously enhance their quality.

“Case Management Accreditation moves us closer to measuring quality across population health management initiatives,” said Margaret E. O’Kane, President, NCQA. “Not only does it add value to existing quality improvement efforts; it also demonstrates an organization’s commitment to the highest degree of improving the quality of their patients’ care.”

ROSEBUD case management is a key area of the RGA ROSE® Consulting Group, a medical management consulting program. RGA ROSE clients receive complimentary case management including an array of industry-leading services and resources to manage complex claims, enhance operational efficiency, and improve patient care. Since 1985, ROSEBUD’s skilled perinatal and neonatal nurse consultants have helped health plans improve health outcomes and reduce costs associated with high-risk pregnancies and infants through dedicated case management. As an example, today ROSE released its NICU Cost Containment Guide to help clients implement strategies to effectively manage NICU claims and contain costs. NICU care for medically complex infants is one of the largest cost drivers for most health plans. ROSEBUD also offers a NICU Levels of Care training for case management and utilization management staff.

RGA’s ROSE Consulting Group fills a critical need in meeting the challenges of today’s dynamic healthcare environment. For more information about ROSE or ROSEBUD, contact to inquire about ROSEBUD consultation services or to request training.

About RGA
Reinsurance Group of America, Incorporated (RGA), a Fortune 500 company, is among the leading global providers of life reinsurance and financial solutions, with approximately $3.3 trillion of life reinsurance in force and assets of $64.5 billion as of December 31, 2018. Founded in 1973, RGA is recognized for its deep technical expertise in risk and capital management, innovative solutions, and commitment to serving its clients. With headquarters in St. Louis, Missouri and operations around the world, RGA delivers expert solutions in individual life reinsurance, individual living benefits reinsurance, group reinsurance, health reinsurance, facultative underwriting, product development, and financial solutions. To learn more about RGA and its businesses, visit the company’s website at

About NCQA
NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. NCQA’s website ( contains information to help consumers, employers and others make more informed health care choices. NCQA can be found online at, on Twitter @ncqa, on Facebook at and on LinkedIn at


Contact Us

Public Relations/Media Contacts:

Lynn Phillips
Vice President, Corporate Communications
T 636.736.2351
Send an email >

Investor Relations Contact:

Jeff Hopson
Senior Vice President,
Investor Relations

T 636.736.2068
Send an email >